m.ostergaard
Submits third-party assay reports on material purchased directly. Based in Tilburg.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.10%
n=10
Suppliers covered
7
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043361 | L-Glutathione (reduced) | WXT | WXT-2512-P2820 | Medutest | 2026-Q2 | 98.10 | 8.47 | 106.1 | Buyer-sourced | 0 | FAIL |
| AX-2026-042306 | 5-Amino-1MQ | TFC | TFC-2508-L2057 | Medutest | 2026-Q1 | 99.75 | 5.49 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041522 | Survodutide | QSC | QSC-2506-B6880 | PeptideMeter | 2025-Q4 | 98.31 | 5.53 | 99.5 | Laboratory-retained | 0 | PASS |
| AX-2025-021038 | BPC-157 | BCH | BCH-2506-D4413 | Janoshik | 2025-Q4 | 99.16 | 6.15 | 95.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019361 | Enclomiphene citrate | HYB | HYB-2510-J6404 | Janoshik | 2025-Q4 | 99.03 | 5.20 | 92.1 | Buyer-sourced | 0 | FAIL |
| AX-2025-019345 | Dihexa | HYB | HYB-2501-T6290 | Kestrel | 2025-Q2 | 99.93 | 6.79 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019756 | Semaglutide | Homopeptide | HOMO-2501-D4523 | Nordanalyt | 2025-Q1 | 99.45 | 5.73 | 105.0 | Buyer-sourced | 0 | PASS |
| AX-2025-019894 | Tirzepatide | HJ | HJ-2501-P5963 | Medutest | 2025-Q1 | 98.01 | 2.51 | 98.6 | Laboratory-retained | 0 | PASS |
| AX-2024-004310 | Retatrutide | QSC | QSC-2408-X7558 | Kestrel | 2024-Q4 | 99.36 | 5.55 | 102.2 | Buyer-sourced | 0 | PASS |
| AX-2024-004312 | Retatrutide | QSC | QSC-2408-X7558 | Janoshik | 2024-Q4 | 99.04 | 5.10 | 94.5 | Buyer-sourced | 0 | PASS |